查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1591901

人源化小鼠和大鼠模型市场：按类型、应用和最终用户划分 - 全球预测 2025-2030

Humanized Mouse & Rat Model Market by Type (Humanized Mouse Model, Humanized Rat Model), Application (Hematopoiesis, Immunology & Infectious Diseases, Neuroscience), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年，人源化小鼠和大鼠模型市值为2.5738亿美元，预计2024年将达到2.7591亿美元，复合年增长率为7.33%，2030年将达到4.2257亿美元，预计将达到1000万美元。

人源化小鼠和大鼠模型市场是生物医学研究的重要领域，旨在开拓和测试复杂人类疾病的可行治疗策略。该领域包括携带人类基因、组织和细胞并提供适应人类生物和病理现象的体内模型的基因工程囓齿动物。对此类模型的需求与理解疾病机制、药物发现和个人化医疗密切相关，并扩展到肿瘤学、免疫学和感染疾病中的应用。最终用途领域多种多样，包括学术和研究机构、製药和生物技术公司以及合约研究组织。

主要市场统计
基准年[2023] 2.5738亿美元
预测年份 [2024] 27591万美元
预测年份 [2030] 4.2257 亿美元
复合年增长率（%） 7.33%

关键的成长要素包括慢性病盛行率的不断上升、对新型治疗解决方案的紧迫性以及促进模型开发的基因组技术的进步。同时，道德问题和高成本为市场扩张带来了挑战。 CRISPR 和其他基因编辑技术的持续创新有可能减少开发时间和成本，同时提高基因人源化的精确度，使公司能够更自信地进行药物测试。然而，市场相关人员必须遵守严格的法律规范，并克服与囓齿动物复杂的遗传和免疫特征人性化相关的技术障碍。

一种创新方法是透过多基因人源化来完善模型并整合人类免疫学成分，以提高我们对人类对治疗的独特反应的了解。学术、临床和工业部门之间的合作和协同效应将加强建模平台并加速转化研究。对于市场参与企业来说，策略重点是建立更全面和高度专业化的人性化模型组合可以释放竞争优势。此外，透过参与利用人工智慧和计算模型的伙伴关係，我们可以彻底改变预测分析并最大限度地提高模型在药物发现中的效用。

总之，虽然存在有希望的机会，但相关人员可以透过利用技术进步、策略联盟和缓解生物医学研究中的常见瓶颈来确保市场的持续成长，从而需要满足对有效人类翻译系统日益增长的需求。

市场动态：快速发展的人源化小鼠和大鼠模型市场的关键市场洞察

人性化小鼠和大鼠模型市场正因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 增加生物医学研究和药物开发活动
    • 日益关注个人化医疗和精准治疗
    • 由于监管要求和道德考虑，需求增加
  • 市场限制因素
    • 人源化小鼠和大鼠的复杂模型开发和检验过程
  • 市场机会
    • 基因工程技术的进展
    • 人源化小鼠和大鼠模型与人类类器官和有机晶片技术的集成
  • 市场挑战
    • 再现人类生理学的局限性

波特五力：驾驭人性化小鼠和大鼠模型市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解人源化小鼠和大鼠模型市场的外部影响

外部宏观环境因素在塑造人源化小鼠和大鼠模型市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助企业预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解人源化小鼠和大鼠模型市场的竞争状况

对人源化小鼠和大鼠模型市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵人源化小鼠及大鼠模型市场厂商绩效评估

FPNV定位矩阵是评估人源化小鼠和大鼠模型市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了人源化小鼠和大鼠模型市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，人源化小鼠和大鼠模型市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 增加生物医学研究和药物开发活动
      • 日益关注个人化医疗和精准治疗
      • 由于监管要求和道德考虑，需求不断增长
    • 抑制因素
      • 人源化小鼠和大鼠的复杂模型开发和检验过程
    • 机会
      • 基因工程技术的进展
      • 将人类类器官和器官晶片技术与人源化小鼠和大鼠模型结合
    • 任务
      • 再现人类生理学的局限性
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章人源化小鼠和大鼠模型市场：依类型

  • 人源化小鼠模型
    • BLT模型
    • Hu-PBL-scid模型
    • Hu-SRC-scid模型
  • 人源化大鼠模型

第七章人源化小鼠与大鼠模型市场：依应用分类

  • 造血作用
  • 免疫学和感染疾病
  • 神经科学
  • 肿瘤学
  • 毒理学

第八章人源化小鼠和大鼠模型市场：依最终使用者分类

  • 学术研究设施
  • 合约研究和製造组织
  • 製药和生物技术公司

第九章北美和南美人源化小鼠和大鼠模型市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太地区人源化小鼠与大鼠模型市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲人源化小鼠及大鼠模型市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Aragen Life Sciences
  • Beijing Vitalstar Biotechnology Co., Ltd.
  • BIOCYTOGEN
  • Champions Oncology, Inc.
  • Charles River Laboratories International, Inc.
  • Crown Bioscience, Inc.
  • Cyagen US Inc.
  • GemPharmatech
  • genOway
  • Harbour BioMed
  • Hera BioLabs
  • inGenious Targeting Laboratory, Inc.
  • Oncodesign Precision Medicine
  • Ozgene Pty Ltd.
  • Pharmatest Services Oy
  • Taconic Biosciences, Inc.
  • The Jackson Laboratory
  • TransCure Bioservices
  • Vivo Bio Tech Ltd.
Product Code: MRR-961BA04A2E3A

The Humanized Mouse & Rat Model Market was valued at USD 257.38 million in 2023, expected to reach USD 275.91 million in 2024, and is projected to grow at a CAGR of 7.33%, to USD 422.57 million by 2030.

The humanized mouse and rat model market is an integral segment of biomedical research, geared towards developing and testing viable therapeutic strategies for complex human diseases. This scope encompasses genetically engineered rodents that carry functioning human genes, tissues, or cells, providing an in-vivo model conforming to human biological and pathological phenomena. The necessity for these models is profound in understanding disease mechanisms, drug discovery, and personalized medicine, extending to applications in oncology, immunology, and infectious diseases. End-use domains stretch across academic and research institutions, pharmaceutical and biotechnology companies, and contract research organizations.

KEY MARKET STATISTICS
Base Year [2023] USD 257.38 million
Estimated Year [2024] USD 275.91 million
Forecast Year [2030] USD 422.57 million
CAGR (%) 7.33%

Key growth factors include the increasing prevalence of chronic diseases, the urgency for novel therapeutic solutions, and advancing genomic technologies enhancing model development. Simultaneously, ethical concerns and high costs challenge market expansion. Opportunities arise from ongoing innovations in CRISPR and other gene-editing technologies, which potentially reduce development times and costs while increasing the precision of genetic humanization, allowing organizations to advance drug testing with higher reliability. However, market players must navigate stringent regulatory frameworks and overcome technical hurdles associated with humanizing complex genetic and immunological traits of rodents.

Innovations lie in enhancing model sophistication through multi-gene humanization and integrating human immune components, offering improved insights into human-specific responses to therapies. Collaborative synergies among academic, clinical, and industrial sectors would catalyze enhanced model platforms, accelerating translational research. For market players, a strategic focus on building portfolios of more comprehensive and highly specialized humanized models can unlock competitive advantages. Additionally, participating in partnerships leveraging AI and computational models could revolutionize predictive analytics, thus maximizing model utility in drug discovery.

In conclusion, while promising opportunities exist, stakeholders must leverage technological advancements and strategic collaborations to mitigate prevailing obstacles, thus ensuring sustained market growth and fulfilling the growing demand for effective human translational systems in biomedical research.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Humanized Mouse & Rat Model Market

The Humanized Mouse & Rat Model Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing number of biomedical research and drug development activities
    • Emerging focus toward personalized medicine and precision therapeutics
    • Rising demand owing to regulatory requirements and ethical considerations
  • Market Restraints
    • Complex model development and validation process of humanized mouse & rats
  • Market Opportunities
    • Growing advancements in genetic engineering technologies
    • Integration of human organoids and organ-on-a-chip technologies with humanized mouse and rat models
  • Market Challenges
    • Limitations in recapitulating human physiology

Porter's Five Forces: A Strategic Tool for Navigating the Humanized Mouse & Rat Model Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Humanized Mouse & Rat Model Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Humanized Mouse & Rat Model Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Humanized Mouse & Rat Model Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Humanized Mouse & Rat Model Market

A detailed market share analysis in the Humanized Mouse & Rat Model Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Humanized Mouse & Rat Model Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Humanized Mouse & Rat Model Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Humanized Mouse & Rat Model Market

A strategic analysis of the Humanized Mouse & Rat Model Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Humanized Mouse & Rat Model Market, highlighting leading vendors and their innovative profiles. These include Aragen Life Sciences, Beijing Vitalstar Biotechnology Co., Ltd., BIOCYTOGEN, Champions Oncology, Inc., Charles River Laboratories International, Inc., Crown Bioscience, Inc., Cyagen US Inc., GemPharmatech, genOway, Harbour BioMed, Hera BioLabs, inGenious Targeting Laboratory, Inc., Oncodesign Precision Medicine, Ozgene Pty Ltd., Pharmatest Services Oy, Taconic Biosciences, Inc., The Jackson Laboratory, TransCure Bioservices, and Vivo Bio Tech Ltd..

Market Segmentation & Coverage

This research report categorizes the Humanized Mouse & Rat Model Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Humanized Mouse Model and Humanized Rat Model. The Humanized Mouse Model is further studied across BLT Model, Hu-PBL-scid Model, and Hu-SRC-scid Model.
  • Based on Application, market is studied across Hematopoiesis, Immunology & Infectious Diseases, Neuroscience, Oncology, and Toxicology.
  • Based on End-User, market is studied across Academic & Research Facilities, Contract research & Manufacturing Organizations, and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing number of biomedical research and drug development activities
      • 5.1.1.2. Emerging focus toward personalized medicine and precision therapeutics
      • 5.1.1.3. Rising demand owing to regulatory requirements and ethical considerations
    • 5.1.2. Restraints
      • 5.1.2.1. Complex model development and validation process of humanized mouse & rats
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing advancements in genetic engineering technologies
      • 5.1.3.2. Integration of human organoids and organ-on-a-chip technologies with humanized mouse and rat models
    • 5.1.4. Challenges
      • 5.1.4.1. Limitations in recapitulating human physiology
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Humanized Mouse & Rat Model Market, by Type

  • 6.1. Introduction
  • 6.2. Humanized Mouse Model
    • 6.2.1. BLT Model
    • 6.2.2. Hu-PBL-scid Model
    • 6.2.3. Hu-SRC-scid Model
  • 6.3. Humanized Rat Model

7. Humanized Mouse & Rat Model Market, by Application

  • 7.1. Introduction
  • 7.2. Hematopoiesis
  • 7.3. Immunology & Infectious Diseases
  • 7.4. Neuroscience
  • 7.5. Oncology
  • 7.6. Toxicology

8. Humanized Mouse & Rat Model Market, by End-User

  • 8.1. Introduction
  • 8.2. Academic & Research Facilities
  • 8.3. Contract research & Manufacturing Organizations
  • 8.4. Pharmaceutical & Biotechnology Companies

9. Americas Humanized Mouse & Rat Model Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Humanized Mouse & Rat Model Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Humanized Mouse & Rat Model Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Aragen Life Sciences
  • 2. Beijing Vitalstar Biotechnology Co., Ltd.
  • 3. BIOCYTOGEN
  • 4. Champions Oncology, Inc.
  • 5. Charles River Laboratories International, Inc.
  • 6. Crown Bioscience, Inc.
  • 7. Cyagen US Inc.
  • 8. GemPharmatech
  • 9. genOway
  • 10. Harbour BioMed
  • 11. Hera BioLabs
  • 12. inGenious Targeting Laboratory, Inc.
  • 13. Oncodesign Precision Medicine
  • 14. Ozgene Pty Ltd.
  • 15. Pharmatest Services Oy
  • 16. Taconic Biosciences, Inc.
  • 17. The Jackson Laboratory
  • 18. TransCure Bioservices
  • 19. Vivo Bio Tech Ltd.

LIST OF FIGURES

  • FIGURE 1. HUMANIZED MOUSE & RAT MODEL MARKET RESEARCH PROCESS
  • FIGURE 2. HUMANIZED MOUSE & RAT MODEL MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. HUMANIZED MOUSE & RAT MODEL MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. HUMANIZED MOUSE & RAT MODEL MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. HUMANIZED MOUSE & RAT MODEL MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. HUMANIZED MOUSE & RAT MODEL MARKET DYNAMICS
  • TABLE 7. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY BLT MODEL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HU-PBL-SCID MODEL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HU-SRC-SCID MODEL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED RAT MODEL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HEMATOPOIESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNOLOGY & INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY NEUROSCIENCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TOXICOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY ACADEMIC & RESEARCH FACILITIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY CONTRACT RESEARCH & MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. HUMANIZED MOUSE & RAT MODEL MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 193. HUMANIZED MOUSE & RAT MODEL MARKET, FPNV POSITIONING MATRIX, 2023